Insider filing · TNGX
Tango Therapeutics, Inc.
TNGX · Healthcare · 23 filings in 24 months
ticker →
EcoR1 Capital, LLC sold $8.4M of Tango Therapeutics (TNGX)
Executed Nov 6 2024, disclosed Nov 8 2024, 2 days later.
Value, as filed
$8.4M
2,700,000 sh across 3 lots
Executed
Nov 6 2024
the trade date, as filed
Disclosed
Nov 8 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EL
EcoR1 Capital, LLC
Director
profile →
EcoR1 Capital, LLC (Director) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (2 purchases, 0 sales), most often in ZYME. Across 2 priced purchase filings, the average 21-session return was +2.8% from execution and -5.0% from disclosure (delay-adjusted; derived). The largest single filing was $40.0M of AKTS (2,222,222 sh across 2 lots, as filed), executed Jan 12.
The name
TNGXHealthcare · Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations wi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→